Generating AI analysis...
AI Earnings Analysis
| Metric | Current | Previous | YoY Change |
|---|---|---|---|
Revenue | $492.72M | $384.1M | +28.28% |
Operating Income | $-640.38M | $-143.79M | -345.37% |
Net Income | $-692.79M | $-163.63M | -323.38% |
EPS (Basic) | $-7.04 | $-3.14 | -124.20% |
EPS (Diluted) | $-7.04 | $-3.14 | -124.20% |
R&D Expense | $119.71M | $66.27M | +80.65% |
SG&A Expense | $644.06M | $211.66M | +204.29% |
| Metric | Current | Previous | YoY Change |
|---|---|---|---|
Total Assets | $971.73M | — | — |
Current Assets | $679.41M | — | — |
Total Liabilities | $918M | — | — |
Current Liabilities | $252.62M | — | — |
Stockholders' Equity | $53.73M | $-1.32B | +104.06% |
Cash & Equivalents | $388.01M | $132.71M | +192.38% |
| Metric | Current | Previous | YoY Change |
|---|---|---|---|
Operating Cash Flow | $-149.79M | $-174.07M | +13.95% |
Investing Cash Flow | $-122.43M | $-34.77M | -252.13% |
Financing Cash Flow | $494.51M | $38.66M | +1179.09% |
Dividends Paid | $5.63M | $5.63M | 0.00% |
| Metric | Current | Previous | YoY Change |
|---|---|---|---|
Operating Margin | -130.0% | -37.4% | -92.53% |
Net Margin | -140.6% | — | — |
ROE | -1289.4% | — | — |
ROA | -71.3% | — | — |
Current Ratio | $2.689 | — | — |
Debt to Equity | $17.086 | — | — |
Other companies in Life Sciences Tools & Services